Skip to main content
. 2024 Jan 2;38:100825. doi: 10.1016/j.lanepe.2023.100825

Table 1.

Baseline demographic and clinical characteristics of subjects by treatment group—ITT population.

Random group
Total (N = 119)
Intervention (N = 58) Control (N = 61)
Age (years) 67 (58–74) 68 (59–75) 67 (58–75)
Sex
 Male 38 (66%) 37 (61%) 75 (63%)
 Female 20 (34%) 24 (39%) 44 (37%)
Time between stroke and BL (days) 21 (10–30) 19 (9–27) 20 (10–28)
Type of stroke
 Cortical 19 (33%) 22 (36%) 41 (34%)
 Subcortical 39 (67%) 39 (64%) 78 (66%)
Lesion side
 Left 31 (53%) 24 (39%) 55 (46%)
 Right 27 (47%) 37 (61%) 64 (54%)
Mini mental status test 29 (26–30)a 29 (28–30)a 29 (27–30)b
UEFMA 36 (28–45) 39 (30–50)c 39 (29–47)c
NIHSS 4.1 (1.7) 3.6 (2.2) 3.8 (2.0)
Barthel Index 63.6 (22.6)d 68.8 (25.2) 66.3 (24.0)
Intravenous thrombolysis
 Yes 17/58 (29%) 18/60 (30%) 35 (30%)
 No 41/58 (71%) 42/60 (70%) 83 (70%)
Edinburgh
 Ambidextrous 11/54 (20%) 13/56 (23%) 24/110 (22%)
 Left handed 1/54 (2%) 0/56 (0%) 1/110 (1%)
 Right handed 42/54 (78%) 43/56 (77%) 85/110 (77%)
Risk factors
 Diabetes mellitus 9 (16%) 16 (26%) 25 (21%)
 Arterial hypertension 42 (72%) 49 (80%) 91 (77%)
 Hyperlipidemia 26/58 (45%) 30/59 (51%) 56/117 (48%)
 Nicotine 14 (24%) 16 (26%) 30 (25%)
 Atrial fibrillation 6/58 (10%) 6/60 (10%) 12/118 (10%)

Data are n (%), median (IQR), mean (SD), or n/N (%).

BL = baseline; UEFMA = Upper-Extremity-Fugl-Meyer-Assessment; NIHSS = National Institutes of Health Stroke Scale.

a

Data is missing for five patients.

b

Data is missing for ten patients.

c

Data is missing for two patients.

d

Data is missing for one patient.